Sublobar Resection

2

Review clinical trials related to Sublobar Resection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tubeless Strategy for Enhanced Recovery After Sublobar Resection

This is a prospective, randomized controlled clinical trial conducted at a single center. The study aims to evaluate whether a "tubeless" strategy can enhance recovery for patients undergoing minimally invasive thoracoscopic sublobar resection (wedge or segment resection) for small lung nodules. Participants will be randomly assigned to one of two groups: * The experimental group will receive the "tubeless" strategy, which includes non-endotracheal intubation anesthesia (using a laryngeal mask) and no routine chest tube drainage after surgery. * The control group will receive the traditional strategy, which includes double-lumen endotracheal intubation anesthesia and routine chest tube drainage. The main goal is to compare the rate of achieving high-quality fast-track recovery at 24 hours after surgery between the two groups. This study will provide evidence on whether the tubeless approach can help patients recover faster and more comfortably without compromising safety.

Participants needed: 138
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Guangzhou Medical UniversityUpdated: Feb 13, 2026Locations: 1
Eligibility criteria

Age between 18 and 75 years. [+4]

Severe pleural adhesions or fibrosis that would preclude non-intubated anesthesi... [+6]

Status: Recruiting

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.

Participants needed: 390
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Dec 13, 2023Locations: 1
Eligibility criteria

Patients who sign the informed consent form and are willing to complete the stud... [+7]

Not cT1N0M0; [+4]